+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Malaria Diagnostics Market Size, Share and Trends Analysis Report by Technology (Microscopy, Rapid Diagnostic Tests), End-use (Clinics, Hospitals), and Region 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 4621717
Description Jump to:
The global malaria diagnostics market size is projected to reach USD 900.5 million by 2030, expanding at a CAGR of 2.6% from 2024 to 2030. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis’s Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis.
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count.
  • Africa led the market in 2023 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region.
  • Southeast Asia is expected to grow at a CAGR of 2.3% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence.

The leading players in the Malaria Diagnostics market include:

  • Access Bio., Inc.
  • Abbott Laboratories
  • Premier Medical Corporation Pvt. Ltd.
  • Sysmex Partec GmbH
  • bioMérieux
  • Beckman Coulter, Inc.
  • Siemens Healthineers
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • Bio-Rad Laboratories, Inc.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
3.2.1.2. Development of technologically advanced and efficient diagnostics
3.2.1.3. Market players and private investors to curb the prevalence of malaria
3.2.2. Market restraint analysis
3.2.2.1. Increasing number of countries in the malaria elimination phase
3.2.2.2. Demand for low-cost malaria diagnostic tests
3.3. Malaria Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Malaria Diagnostics Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Molecular Diagnostic Tests
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Conventional PCR
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Modernized PCR
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Microscopy
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Diagnostic Tests (RDT)
Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis
5.1. Method Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Malaria Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals & Clinics
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Diagnostic Centers
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Academic and Research Institutes
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. Africa
6.5.1. Nigeria
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Democratic Republic of the Congo
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. United Republic of Tanzania
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Uganda
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Africa
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Mozambique
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Angola
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Ghana
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.9. Botswana
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.10. Namibia
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
6.6. South East Asia
6.6.1. India
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Myanmar
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Indonesia
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Eastern Mediterranean
6.7.1. Saudi Arabia
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Pakistan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Western Pacific
6.8.1. China
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Papua New Guinea
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Cambodia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Americas
6.9.1. Venezuela
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Brazil
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Colombia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Europe
6.10.1. UK
6.10.1.1. Key country dynamics
6.10.1.2. Regulatory framework/ reimbursement structure
6.10.1.3. Competitive scenario
6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.10.2. Germany
6.10.2.1. Key country dynamics
6.10.2.2. Regulatory framework/ reimbursement structure
6.10.2.3. Competitive scenario
6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.10.3. France
6.10.3.1. Key country dynamics
6.10.3.2. Regulatory framework/ reimbursement structure
6.10.3.3. Competitive scenario
6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.10.4. Turkey
6.10.4.1. Key country dynamics
6.10.4.2. Regulatory framework/ reimbursement structure
6.10.4.3. Competitive scenario
6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Access Bio, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Premier Medical Corporation Pvt. Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Sysmex Partec GmbH
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. bioMérieux
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Beckman Coulter, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Leica Microsystems GmbH
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Bio-Rad Laboratories, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Africa malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 3 Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 5 Nigeria malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 6 Nigeria malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Democratic Republic of Congo malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 8 Democratic Republic of Congo malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Uganda malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 10 Uganda malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 United Republic of Tanzania malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 12 United Republic of Tanzania malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 13 South Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 South Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15 Mozambique malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 16 Mozambique malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 17 Angola malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Angola malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 19 Ghana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 20 Ghana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 21 Botswana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Botswana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 23 Namibia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 24 Namibia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 25 South East Asia malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 26 South East Asia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 27 South East Asia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 India malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 29 India malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Myanmar malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 Myanmar malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 32 Indonesia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 33 Indonesia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 34 Eastern Mediterranean malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 35 Eastern Mediterranean malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 36 Eastern Mediterranean malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Saudi Arabia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 38 Saudi Arabia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Pakistan malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 40 Pakistan malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Western Pacific malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 42 Western Pacific malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Western Pacific malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 44 China malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 45 China malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 46 Papua New Guinea malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Papua New Guinea malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Cambodia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 49 Cambodia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Americas malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 51 Americas malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 52 Americas malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 Venezuela malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 54 Venezuela malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 55 Brazil malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 56 Brazil malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Colombia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 58 Colombia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 Europe malaria diagnostics market, by country, 2018 - 2030 (USD Million)
Table 60 Europe malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 61 Europe malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 62 Turkey malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Turkey malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 64 France malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 65 France malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 UK malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 67 UK malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 68 Germany malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 69 Germany malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Africa
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in South East Asia
Fig. 7 Primary interviews in Eastern Mediterranean
Fig. 8 Primary interviews in Western Pacific
Fig. 9 Primary interviews in Americas
Fig. 10 Primary interviews in Europe
Fig. 11 Market research approaches
Fig. 12 Value-chain-based sizing & forecasting
Fig. 13 QFD modeling for market share assessment
Fig. 14 Market formulation & validation
Fig. 15 Malaria Diagnostics market: market outlook
Fig. 16 Malaria Diagnostics competitive insights
Fig. 17 Parent market outlook
Fig. 18 Related/ancillary market outlook
Fig. 19 Penetration and growth prospect mapping
Fig. 20 Industry value chain analysis
Fig. 21 Malaria Diagnostics market driver impact
Fig. 22 Malaria Diagnostics market restraint impact
Fig. 23 Malaria Diagnostics market strategic initiatives analysis
Fig. 24 Malaria Diagnostics market: Technology movement analysis
Fig. 25 Malaria Diagnostics market: Technology outlook and key takeaways
Fig. 26 Molecular Diagnostic Tests market estimates and forecasts, 2018 - 2030
Fig. 27 Conventional PCR market estimates and forecasts, 2018 - 2030
Fig. 28 Modernized PCR market estimates and forecasts, 2018 - 2030
Fig. 29 Microscopy market estimates and forecasts, 2018 - 2030
Fig. 30 Rapid Diagnostic Tests (RDT) market estimates and forecasts, 2018 - 2030
Fig. 31 Malaria Diagnostics market: End Use movement analysis
Fig. 32 Malaria Diagnostics market: End Use outlook and key takeaways
Fig. 33 Hospitals & Clinics market estimates and forecasts, 2018 - 2030
Fig. 34 Diagnostic Centers market estimates and forecasts, 2018 - 2030
Fig. 35 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
Fig. 36 Global malaria diagnostics market: Regional movement analysis
Fig. 37 Global malaria diagnostics market: Regional outlook and key takeaways
Fig. 38 Global malaria diagnostics market share and leading players
Fig. 39 Africa market share and leading players
Fig. 40 Europe market share and leading players
Fig. 41 South East Asia market share and leading players
Fig. 42 Eastern Mediterranean market share and leading players
Fig. 43 Western Pacific market share and leading players
Fig. 44 Americas market share and leading players
Fig. 45 Africa market estimates and forecasts, 2018 - 2030
Fig. 46 Nigeria market estimates and forecasts, 2018 - 2030
Fig. 47 Democratic Republic of Congo market estimates and forecasts, 2018 - 2030
Fig. 48 Uganda market estimates and forecasts, 2018 - 2030
Fig. 49 United Republic of Tanzania market estimates and forecasts, 2018 - 2030
Fig. 50 South Africa market estimates and forecasts, 2018 - 2030
Fig. 51 Mozambique market estimates and forecasts, 2018 - 2030
Fig. 52 Angola market estimates and forecasts, 2018 - 2030
Fig. 53 Ghana market estimates and forecasts, 2018 - 2030
Fig. 54 Botswana market estimates and forecasts, 2018 - 2030
Fig. 55 Namibia market estimates and forecasts, 2018 - 2030
Fig. 56 Europe market estimates and forecasts, 2018 - 2030
Fig. 57 UK market estimates and forecasts, 2018 - 2030
Fig. 58 Germany market estimates and forecasts, 2018 - 2030
Fig. 59 France market estimates and forecasts, 2018 - 2030
Fig. 60 Turkey market estimates and forecasts, 2018 - 2030
Fig. 61 South East Asia market estimates and forecasts, 2018 - 2030
Fig. 62 India market estimates and forecasts, 2018 - 2030
Fig. 63 Myanmar market estimates and forecasts, 2018 - 2030
Fig. 64 Indonesia market estimates and forecasts, 2018 - 2030
Fig. 65 Eastern Mediterranean market estimates and forecasts, 2018 - 2030
Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 67 Pakistan market estimates and forecasts, 2018 - 2030
Fig. 68 Western Pacific market estimates and forecasts, 2018 - 2030
Fig. 69 China market estimates and forecasts, 2018 - 2030
Fig. 70 Papua New Guinea market estimates and forecasts, 2018 - 2030
Fig. 71 Cambodia market estimates and forecasts, 2018 - 2030
Fig. 72 Americas market estimates and forecasts, 2018 - 2030
Fig. 73 Venezuela market estimates and forecasts, 2018 - 2030
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
Fig. 76 Market share of key market players- Malaria Diagnostics market

Companies Mentioned

The leading players in the Malaria Diagnostics market include:
  • Access Bio., Inc.
  • Abbott Laboratories
  • Premier Medical Corporation Pvt. Ltd.
  • Sysmex Partec GmbH
  • bioMérieux
  • Beckman Coulter, Inc.
  • Siemens Healthineers
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • Bio-Rad Laboratories, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedSeptember 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 759.1 Million
Forecasted Market Value ( USD ) by 2030 $ 900.5 Million
Compound Annual Growth Rate2.6%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Malaria Diagnostics - A Global Market Overview - Product Image

Malaria Diagnostics - A Global Market Overview

  • Report
  • 295 Pages
  • Global
From
Malaria Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Malaria Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Malaria Diagnostics Market Report by Technology, End Use, and Region 2024-2032 - Product Image

Malaria Diagnostics Market Report by Technology, End Use, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Malaria Diagnostics - Global Strategic Business Report - Product Image

Malaria Diagnostics - Global Strategic Business Report

  • Report
  • 162 Pages
  • Global
From
Malaria Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Malaria Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From

About the Malaria Test Market

The Malaria Test market is a subset of the larger Infectious Disease Testing market. It is focused on the diagnosis of malaria, a mosquito-borne disease caused by a parasite. Malaria tests are used to detect the presence of the parasite in a patient's blood sample. Tests can be performed in a laboratory or at the point of care, and can be used to diagnose both acute and chronic cases of malaria. The Malaria Test market is driven by the prevalence of the disease in certain regions, as well as the need for rapid diagnosis and treatment. The market is expected to grow in the coming years, as new technologies are developed to improve the accuracy and speed of diagnosis. Some companies in the Malaria Test market include Abbott, Alere, Bio-Rad, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.